ARS Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $351.2M
Liabilities Breakdown FY2024
Total Liabilities: $94.4M
Asset Breakdown
Total Assets: $351.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $50.8M | 14.5% |
| Accounts Receivable | $8.2M | 2.3% |
| Inventory | $10.5M | 3.0% |
| Property, Plant & Equipment | $1.1M | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $7.4M | 2.1% |
| Other Assets | $273.2M | 77.8% |
Liabilities Breakdown
Total Liabilities: $94.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.9M | 10.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $84.5M | 89.5% |